Published in Cancer Epidemiol Biomarkers Prev on July 06, 2012
Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma. Cancer (2015) 2.96
Survival disparities by insurance type for patients aged 15-64 years with non-Hodgkin lymphoma. Oncologist (2015) 0.95
US trends in survival disparities among adolescents and young adults with non-Hodgkin lymphoma. Cancer Causes Control (2015) 0.83
Residence proximity to benzene release sites is associated with increased incidence of non-Hodgkin lymphoma. Cancer (2013) 0.83
Racial differences in mantle cell lymphoma in the United States. BMC Cancer (2014) 0.78
Racial differences in chronic lymphocytic leukemia. Digging deeper. Cancer (2013) 0.76
Trends and Predictors of Chemotherapy Use among Thyroid Cancer Patients in the National Cancer Database (2004-2013). Eur Thyroid J (2016) 0.75
Relations Between Residential Proximity to EPA-Designated Toxic Release Sites and Diffuse Large B-Cell Lymphoma Incidence. South Med J (2016) 0.75
Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era. Br J Haematol (2017) 0.75
Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma. Leuk Lymphoma (2015) 0.75
Identifying racial differences in nodular lymphocyte-predominant Hodgkin lymphoma. Cancer (2015) 0.75
The diffusion of docetaxel in patients with metastatic prostate cancer. J Natl Cancer Inst (2014) 0.75
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin (2011) 30.81
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med (2002) 24.07
Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health (1992) 20.06
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med (2002) 19.60
A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med (1993) 17.71
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol (2006) 8.53
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol (2006) 7.14
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med (1993) 6.77
Racial and ethnic disparities in health care: a position paper of the American College of Physicians. Ann Intern Med (2004) 6.76
Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med (1998) 5.74
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol (2008) 5.50
Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol (2005) 4.99
Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care (2002) 4.88
Survival of blacks and whites after a cancer diagnosis. JAMA (2002) 4.27
Approaches for estimating prevalence ratios. Occup Environ Med (2008) 3.88
Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood (1998) 2.83
Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma. J Clin Oncol (2001) 2.47
Improving outcomes for patients with diffuse large B-cell lymphoma. CA Cancer J Clin (2010) 1.97
Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005). J Natl Cancer Inst (2008) 1.91
Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer (1976) 1.85
Clinical investigators as critical determinants in pharmaceutical innovation. Nat Med (1997) 1.57
Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma. Cancer (2008) 1.53
Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer (2010) 1.38
Diversifying the racial and ethnic composition of the physician workforce. Ann Intern Med (2004) 1.11
Prostate cancer in black and white Americans. Cancer Metastasis Rev (2003) 1.05
Diffuse aggressive lymphoma. Hematology Am Soc Hematol Educ Program (2004) 1.05
Outcome of diffuse large B-Cell lymphoma in the United States has improved over time but racial disparities remain: review of SEER data. Clin Lymphoma Myeloma Leuk (2011) 0.98
Racial differences in the incidence and outcomes for patients with hematological malignancies. Curr Probl Cancer (2007) 0.88
From unequal treatment to quality care. Ann Intern Med (2004) 0.84
Cancer-related disparities: weathering the perfect storm through comprehensive cancer control approaches. Cancer Causes Control (2005) 0.82
Lung cancer and race: equal treatment yields equal outcome among equal patients, but there is no equal treatment. J Clin Oncol (2005) 0.82
Patterns of social support among lymphoma patients considering stem cell transplantation. Soc Work Health Care (2011) 0.81
Improving uniformity of care for colorectal cancers through National Quality Forum quality indicators at a Commission on Cancer-accredited community based teaching hospital. Surg Oncol Clin N Am (2011) 0.78
The Patient's role in reducing disparities. Ann Intern Med (2004) 0.77
Effect of dutasteride on the risk of prostate cancer. N Engl J Med (2010) 12.78
Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev (2010) 12.60
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Are racial and ethnic minorities less willing to participate in health research? PLoS Med (2005) 7.88
Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2004) 7.02
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer (2009) 5.55
Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2010) 4.76
Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol (2008) 4.49
Survival of blacks and whites after a cancer diagnosis. JAMA (2002) 4.27
Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer (2013) 4.24
Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin (2012) 4.13
The global burden of cancer: priorities for prevention. Carcinogenesis (2009) 3.73
Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer. J Thorac Oncol (2013) 3.67
Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2009) 3.25
Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat (2002) 3.19
American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16
Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev (2009) 3.08
Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat (2008) 2.97
Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol (2012) 2.82
Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2011) 2.76
Unintended consequences of health information technology: evidence from veterans affairs colorectal cancer oncology watch intervention. J Clin Oncol (2012) 2.67
Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol (2011) 2.65
The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer (2010) 2.63
Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base. Eur Urol (2012) 2.61
Insurance status and stage of cancer at diagnosis among women with breast cancer. Cancer (2007) 2.43
American society of clinical oncology policy statement: disparities in cancer care. J Clin Oncol (2009) 2.12
Low-dose spiral CT screening and evaluation of the solitary pulmonary nodule. Oncology (Williston Park) (2014) 2.06
Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening. CA Cancer J Clin (2015) 1.97
Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin (2014) 1.95
The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol (2008) 1.93
Recent trends in Black-White disparities in cancer mortality. Cancer Epidemiol Biomarkers Prev (2008) 1.86
Treatment of muscle invasive bladder cancer: evidence from the National Cancer Database, 2003 to 2007. J Urol (2010) 1.83
Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin (2013) 1.75
Palliative care and the quality of life. J Clin Oncol (2011) 1.75
Patient-reported outcomes: conceptual issues. Value Health (2007) 1.72
Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation. Health Aff (Millwood) (2013) 1.63
Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006. J Clin Oncol (2010) 1.58
Disparities in receipt of lymph node biopsy among early-stage female breast cancer patients. Ann Surg Oncol (2008) 1.57
Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study. Cancer Prev Res (Phila) (2013) 1.56
Prevalence of prehypertension and its relationship to risk factors for cardiovascular disease in Jamaica: analysis from a cross-sectional survey. BMC Cardiovasc Disord (2008) 1.55
Pesticide contamination inside farm and nonfarm homes. J Occup Environ Hyg (2005) 1.52
Insurance status, comorbidity level, and survival among colorectal cancer patients age 18 to 64 years in the National Cancer Data Base from 2003 to 2005. J Clin Oncol (2009) 1.49
Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst (2002) 1.44
Screening adults for pre-diabetes and diabetes may be cost-saving. Diabetes Care (2010) 1.44
High prevalence of triple-negative tumors in an urban cancer center. Cancer (2008) 1.43
The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database. Cancer J (2010) 1.43
Trends in the incidence of colorectal cancer in relation to county-level poverty among blacks and whites. J Natl Med Assoc (2008) 1.42
Effects of untreated syphilis in the negro male, 1932 to 1972: a closure comes to the Tuskegee study, 2004. Urology (2005) 1.42
Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer (2010) 1.38
Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev (2012) 1.36
Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Cancer (2008) 1.36
Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data. Cancer (2012) 1.33
Transcending the volume-outcome relationship in cancer care. J Natl Cancer Inst (2006) 1.33
Trends in colorectal cancer incidence rates by age, race/ethnicity, and indices of access to medical care, 1995–2004 (United States). Cancer Causes Control (2009) 1.33
The impact of health insurance status on stage at diagnosis of oropharyngeal cancer. Cancer (2007) 1.30
Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program. Cancer (2010) 1.28
Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis. Am J Clin Oncol (2008) 1.28
Mortality and exposure response among 14,458 electrical capacitor manufacturing workers exposed to polychlorinated biphenyls (PCBs). Environ Health Perspect (2006) 1.25
The value of new chemotherapeutic agents for metastatic colorectal cancer. Arch Intern Med (2010) 1.25
Health insurance and stage at diagnosis of laryngeal cancer: does insurance type predict stage at diagnosis? Arch Otolaryngol Head Neck Surg (2007) 1.22
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER. Endocr Pract (2015) 1.22
Changes in smoking prevalence among U.S. adults by state and region: Estimates from the Tobacco Use Supplement to the Current Population Survey, 1992-2007. BMC Public Health (2011) 1.21
Individual lifetime exposure to inorganic arsenic using a space-time information system. Int Arch Occup Environ Health (2006) 1.21
Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer: An Analysis from the National Cancer Data Base. J Thorac Oncol (2015) 1.18
Body mass index in young adulthood and premature death: analyses of the US National Health Interview Survey linked mortality files. Am J Epidemiol (2011) 1.15
Reproductive factors and risk of glioma in women. Cancer Epidemiol Biomarkers Prev (2004) 1.14
Measuring outcomes in randomized prospective trials in palliative care. J Pain Symptom Manage (2007) 1.13
Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006. Cancer Epidemiol Biomarkers Prev (2010) 1.12
Racial disparities in colorectal cancer. Curr Probl Cancer (2007) 1.11
Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States. Clin Lymphoma Myeloma Leuk (2011) 1.11
Urinary and hand wipe pesticide levels among farmers and nonfarmers in Iowa. J Expo Anal Environ Epidemiol (2005) 1.10
From the guest editors: introduction for the impact of health care reform on cancer patients. Cancer J (2010) 1.08
Race and ethnicity are associated with delays in breast cancer treatment (2003-2006). J Health Care Poor Underserved (2011) 1.08
Current treatment of head and neck squamous cell cancer. J Surg Oncol (2014) 1.07
Colorectal carcinoma in black and white race. Cancer Metastasis Rev (2003) 1.07
Impact of health care reform legislation on uninsured and medicaid-insured cancer patients. Cancer J (2010) 1.06
Patient-reported outcomes assessment in cancer trials: evaluating and enhancing the payoff to decision making. J Clin Oncol (2007) 1.06
Next steps for use of item response theory in the assessment of health outcomes. Qual Life Res (2007) 1.06
Prostate cancer: current evidence weighs against population screening. CA Cancer J Clin (2009) 1.05
Prostate cancer in black and white Americans. Cancer Metastasis Rev (2003) 1.05
Disparities associated with advanced prostate cancer stage at diagnosis. J Health Care Poor Underserved (2010) 1.05
Prospective studies of body mass index with head and neck cancer incidence and mortality. Cancer Epidemiol Biomarkers Prev (2012) 1.05
Long-term quality of life after total laryngectomy. Head Neck (2006) 1.04
Factors associated with colon cancer stage at diagnosis. Dig Dis Sci (2009) 1.04
Spillover effects of state mandated benefit laws: the case of outpatient breast cancer surgery. Inquiry (2010) 1.04
Insurance status is related to diffuse large B-cell lymphoma survival. Cancer (2014) 1.04
Reflections on findings of the Cancer Outcomes Measurement Working Group: moving to the next phase. J Natl Cancer Inst (2005) 1.04
Insurance status and survival disparities among nonelderly rectal cancer patients in the National Cancer Data Base. Cancer (2010) 1.04
IARC monographs: 40 years of evaluating carcinogenic hazards to humans. Environ Health Perspect (2015) 1.03
Association of insurance status and age with cervical cancer stage at diagnosis: National Cancer Database, 2000-2007. Am J Public Health (2012) 1.02